RESUMO
MicroRNAs (miRNAs) play regulatory roles in several diseases. In schistosomiasis, the main pathological changes are caused by the granulomatous reaction induced by egg deposition. We aimed to study the changes in host miRNA-223 and miRNA-146b expression in relation to egg deposition and development of hepatic pathology in murine schistosomiasis mansoni. Blood and liver tissue samples were collected from non-infected mice (group I), S. mansoni-infected mice at the 4th, 8th, and 12th weeks post-infection (p.i.) (groups II-IV), and 4 weeks after praziquantel treatment (group V). The collected samples were processed for RNA extraction, reverse transcription, and real-time PCR analysis of miRNA-223 and miRNA-146b. miRNAs' relative expression was estimated by the ΔΔCt method. Liver tissue samples were examined for egg count estimation and histopathological evaluation. Results revealed that miRNA-223 was significantly downregulated in liver tissues 8 and 12 weeks p.i., whereas miRNA-146b expression increased gradually with the progression of infection with a significantly higher level at week 12 p.i. compared to week 4 p.i. Serum expression levels nearly followed the same pattern as the tissue levels. The dysregulated expression of miRNAs correlated with liver egg counts and was more obvious with the demonstration of chronic granulomas, fibrous transformation, and distorted hepatic architecture 12 weeks p.i. Restoration of normal expression levels was observed 4 weeks after treatment. Collectively, these findings provide new insights for in-depth understanding of host-parasite interaction in schistosomiasis and pave a new way for monitoring the progress of hepatic pathology before and after treatment.
Assuntos
MicroRNAs , Esquistossomose mansoni , Esquistossomose , Animais , Fígado/parasitologia , Camundongos , MicroRNAs/genética , Schistosoma mansoni/genética , Esquistossomose/patologia , Esquistossomose mansoni/genética , Esquistossomose mansoni/patologiaRESUMO
Toxoplasmosis is a zoonotic disease and a global food and water-borne infection. The disease is caused by the parasite Toxoplasma gondii, which is a highly successful and remarkable pathogen because of its ability to infect almost any nucleated cell in warm-blooded animals. The present study was done to demonstrate the effect of protease inhibitors cocktail (PIC), which inhibit both cysteine and serine proteases, on in vitro cultured T. gondii tachyzoites on HepG2 cell line. This was achieved by assessing its effect on the invasion of the host cells and the intracellular development of T.gondii tachyzoites through measuring their number and viability after their incubation with PIC. Based on the results of the study, it was evident that the inhibitory action of the PIC was effective when applied to tachyzoites before their cultivation on HepG2 cells. Pre-treatment of T.gondii tachyzoites with PIC resulted in failure of the invasion of most of the tachyzoites and decreased the intracellular multiplication and viability of the tachyzoites that succeeded in the initial invasion process. Ultrastructural studies showed morphological alteration in tachyzoites and disruption in their organelles. This effect was irreversible till the complete lysis of cell monolayer in cultures. It can be concluded that PIC, at in vitro levels, could prevent invasion and intracellular multiplication of Toxoplasma tachyzoites. In addition, it is cost effective compared to individual protease inhibitors. It also had the benefit of combined therapy as it lowered the concentration of each protease inhibitor used in the cocktail. Other in vivo experiments are required to validate the cocktail efficacy against toxoplasmosis. Further studies may be needed to establish the exact mechanism by which the PIC exerts its effect on Toxoplasma tachyzoites behavior and its secretory pathway.
Assuntos
Inibidores de Proteases/farmacologia , Toxoplasma/efeitos dos fármacos , Análise de Variância , Animais , Aprotinina/farmacologia , Meios de Cultura Livres de Soro , Inibidores de Cisteína Proteinase/farmacologia , Combinação de Medicamentos , Células Hep G2 , Humanos , Leucina/análogos & derivados , Leucina/farmacologia , Leupeptinas/farmacologia , Camundongos , Microscopia Eletrônica de Transmissão , Organelas/efeitos dos fármacos , Organelas/ultraestrutura , Projetos Piloto , Inibidores de Serina Proteinase/farmacologia , Estatísticas não Paramétricas , Sulfonas/farmacologia , Toxoplasma/enzimologia , Toxoplasma/crescimento & desenvolvimento , Toxoplasma/ultraestruturaRESUMO
Toxoplasmosis is a parasitic infection caused by Toxoplasma gondii protozoon. It is most commonly treated by pyrimethamine (PYR); however, this was intolerable by many patients. The aim of this study was to assess therapeutic effects of Nigella sativa oil (NSO) alone and combined with pyrimethamine (PYR) compared to a previous combination of clindamycin (CLN) and (PYR). One hundred Albino mice were used in the current study and were equally divided into five groups: normal (I), infected untreated control (II); infected, treated with NSO-only (III); infected, treated with NSO + PYR (IV); and infected, treated with CLN + PYR (V). The virulent RH Toxoplasma strain was used in infection survival rates estimation, impression smears from liver and spleen, and histopathological and ultrastructural studies were done. Liver malondialdehyde (MDA) level and total antioxidant capacity (TAC) were determined. Interferon-γ and specific IgM were also measured in sera by ELISA. Results showed that NSO alone has no direct anti-Toxoplasma effect, whereas its combination with PYR produced potent effect that is comparable to CLN + PYR. It significantly increased the survival rate and decreased the parasite density and pathological insult in both liver and spleen. Also, significant increase in interferon-γ level denotes stimulation of cellular immunity. NSO + PYR combination markedly improved the antioxidant capacity of Toxoplasma infected mice compared to the infected untreated ones and to CLN/PYR. In conclusion, although NSO, if administered alone, has significant immunostimulant and antioxidant properties, it failed to decrease tachyzoite counts. Combination of NSO and PYR had synergistic effect in treatment of toxoplasmosis.
Assuntos
Antiprotozoários/uso terapêutico , Nigella sativa/química , Óleos de Plantas/uso terapêutico , Pirimetamina/uso terapêutico , Toxoplasmose/tratamento farmacológico , Animais , Antioxidantes/análise , Antiprotozoários/efeitos adversos , Antiprotozoários/farmacologia , Quimioterapia Combinada , Humanos , Imunoglobulina M/sangue , Interferon gama/sangue , Fígado/química , Fígado/efeitos dos fármacos , Fígado/parasitologia , Fígado/patologia , Masculino , Malondialdeído/análise , Camundongos , Carga Parasitária , Óleos de Plantas/farmacologia , Pirimetamina/efeitos adversos , Pirimetamina/farmacologia , Baço/química , Baço/efeitos dos fármacos , Baço/parasitologia , Baço/patologia , Toxoplasma/efeitos dos fármacos , Toxoplasma/patogenicidade , Toxoplasma/ultraestrutura , Toxoplasmose/imunologia , Toxoplasmose/parasitologia , VirulênciaRESUMO
Toxoplasmosis is a zoonotic protozoal disease that has a major significance from the perspectives of public health and veterinary medicine. Therefore, an obvious long-term goal of many scientists would be the development of an effective vaccine. In this study, autoclaved vaccine was evaluated for its ability to protect mice against Toxoplasma gondii RH challenge as an acute infection model. Results showed that autoclaved Toxoplasma vaccine (ATV) when combined with BCG as an adjuvant was effective in triggering cell mediated immunity as shown by a significant increase in the percentage of splenic CD8+ T-lymphocytes. Following challenge, death of mice vaccinated with ATV was delayed for nine days. There was a significant decrease in parasite density in different organs, and a marked reduction of pathological changes in the liver suggesting that significant immune responses were mounted following vaccination. Future studies are warranted to test the vaccine against challenge with brain cysts as a chronic infection model and to evaluate it with other recent immunization strategies that can further enhance its immunogenicity.
Assuntos
Vacinas Protozoárias/normas , Toxoplasma/imunologia , Toxoplasmose Animal/prevenção & controle , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/normas , Animais , Encéfalo/parasitologia , Linfócitos T CD8-Positivos/citologia , Esquemas de Imunização , Injeções Intradérmicas , Fígado/parasitologia , Pulmão/parasitologia , Contagem de Linfócitos , Masculino , Camundongos , Mycobacterium bovis/imunologia , Vacinas Protozoárias/administração & dosagem , Baço/citologia , Baço/imunologia , Baço/parasitologia , Esterilização , Taxa de Sobrevida , Toxoplasmose Animal/mortalidadeRESUMO
Biomphalaria species that act as an intermediate host for Schistosoma mansoni have different degrees of susceptibility and different internal defense system responses against parasites. Of these species, Biomphalaria alexandrina represents the only intermediate host in Egypt. Given the limited data on the efficacy of the B. alexandrina internal defense system in comparison to that of other species, we sought to better understand its defense against S. mansoni. We performed in vitro hemocyte adherence assay using whole hemolymph and in vitro reaction using the hemocyte-free hemolymph of susceptible and resistant snails against transformed mother sporocysts. The results demonstrated that the interacting factors between the parasite and the hemolymph of the resistant and susceptible snails do not act in a similar manner. Destruction of the parasite was a restricted function of the hemocytes among resistant snails only. This study demonstrates the key role played by snail hemocytes as a first line of defense against the parasite. The incubation of the hemocyte-free hemolymph of both susceptible and resistant snails with the sporocysts did not lead to any changes in the sporocysts shape or integrity. This immunological variance demonstrated between susceptible and resistant snails could be useful to differentiate between susceptible and resistant snails in future field studies. In addition, the results may help further studies to explain the process of attraction, encapsulation and subsequent killing of S. mansoni in its intermediate host.
Assuntos
Biomphalaria/parasitologia , Interações Hospedeiro-Parasita , Schistosoma mansoni/fisiologia , Animais , Biomphalaria/imunologia , Adesão Celular , Resistência à Doença , Suscetibilidade a Doenças , Egito , Hemócitos/imunologia , Hemócitos/parasitologia , Hemolinfa , Oocistos , Schistosoma mansoni/imunologiaRESUMO
Much effort has been made to control schistosomiasis infection in Egypt. However, enduring effects from such strategies have not yet been achieved. In this study, we sought to determine the genetic variability related to the interaction between Biomphalaria alexandrina snails and Schistosoma mansoni. Using RAPD-PCR with eight (10 mers) random primers, we were able to determine the polymorphic markers that differed between snails susceptible and resistant to Schistosoma mansoni infection using five primers out of the eight. Our results suggest that the RAPD-PCR technique is an efficient means by which to compare genomes and to detect genetic variations between schistosomiasis intermediate hosts. The RAPD technique with the above-noted primers can identify genomic markers that are specifically related to the Biomphalaria alexandrina/Schistosoma mansoni relationship in the absence of specific nucleotide sequence information. This approach could be used in epidemiologic surveys to investigate genetic diversity among Biomphalaria alexandrina snails. The ability to determine resistant markers in Biomphalaria alexandrina snails could potentially lead to further studies that use refractory snails as agents to control the spread of schistosomiasis.
Assuntos
Marcadores Genéticos/genética , Variação Genética/genética , Polimorfismo de Nucleotídeo Único/genética , Esquistossomose mansoni/genética , Esquistossomose mansoni/veterinária , Caramujos/genética , Caramujos/microbiologia , Animais , Mapeamento Cromossômico , Resistência à Doença/genética , Predisposição Genética para Doença/genéticaRESUMO
Of the several species of Biomphalaria snails worldwide that serve as the intermediate host for Schistosoma mansoni, Biomphalaria alexandrina is a species that is indigenous to Egypt. Recently, there has been much debate concerning the presence of Biomphalaria glabrata and the hybrid of the species with Biomphalaria alexandrina. Due to this debate, the absence of a clear explanation for the presence of B. glabrata in Egyptian water channels and the probability that they may be reintroduced, we conducted this field study to identify Biomphalaria species present in Alexandria water channels. Laboratory-adapted susceptible snails to Schistosoma mansoni of the following species were used as a reference; Biomphalaria alexandrina, Biomphalaria glabrata and their hybrid. These snails were used to perpetuate the Schistosoma life cycle at the Theodor Bilharz Research Institute (TBRI), Cairo, Egypt. Morphological and molecular studies were conducted on these reference snails as well as on the first generation of Biomphalaria snails from two areas in the Alexandria governorate. The morphological study included both external shell morphology and internal anatomy of the renal ridge. The molecular study used a species-specific PCR technique. The results demonstrated that there was an absence of Biomphalaria glabrata and the hybrid from Alexandria water channels. Moreover, the susceptibility patterns of these reference snails were studied by measuring the different parasitological parameters. It was found that Biomphalaria glabrata and the hybrid were significantly more susceptible than Biomphalaria alexandrina to the Egyptian strain of Schistosoma mansoni. The results demonstrated that if Biomphalaria glabrata was reintroduced and adapted to the local environment in Egypt, it would have important epidemiologic impacts that would have a serious effect on the health of Egyptian people.